Clinical Pathway of Diagnosis and Treatment of Left Ventricular Hypertrophy:Chinese Expert Consensus 2023
Left ventricular hypertrophy(LVH)is a common form of cardiac structure change,which could be identified via cardiac imaging mordalities.The diagnosis and treatment of LVH is inclined to delay by insidious onset and atypical features in early phase.Many risk factors can lead to LVH.More recently,some etiologyspecific treatments show significant important in terms of therapy efficacy and significantly improve the prognosis in pateinst with LVH.Thus,it is of importance to pay attention to etiological diagnosis of LVH.Experts from the Heart Failure Core Group of the Cardiovascular Physicians Branch of the Chinese Medical Doctor Association and the Expert Committee of the Chinese Heart Failure Center on Cardiomyopathy jointly developed this consensus to summarize the early screening,diagnosis and treatment regimens,and follow-up pathway of LVH.This consensus is aimed to strengthen the understanding of LVH in frontline healthcare workers,especially the community physicians,to reduce the risk of misdiagnosis or missed diagnosis of LVH.
left ventricular hypertrophyearly screeningdiagnosis pathwaytreatment pathwayetiological diagnosishypertrophic cardiomyopathycardiac amyloidosisAnderson-Fabry disease
NETL
NSTL
万方数据
维普
